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(received 8/30/99
Ms. Elaine M. Lehnert
Accounting Standards File 3162
American Institute of Certified Public Accountants 
1211 Avenue of the Americas 
New York, NY 10036-8775
RE: “Discussion Paper: Accounting by Life Insurance Enterprises for Deferred Acquisition Costs 
on Internal Replacements Other Than Those Covered BY FASB Statement No. 97”
Dear Ms. Lehnert:
USAA appreciates the opportunity to participate in the discussion on the above-referenced topic. 
This topic is timely for us as we are currently involved in several inforce conversion initiatives and 
have had to address how to appropriately account for these conversions. Our comments are 
outlined below.
Issue 1: Is authoritative guidance needed on the accounting for DAC in situations characterized 
as interna, replacements.
We are skeptical that such guidance would be useful. Our primary concern is that the guidance 
would restrict insurance enterprises in their ability to engage in relatively common and important 
activities by imposing exceptionally adverse reporting consequences on certain transactions. The 
ability of an insurance enterprise to reform contracts is one such activity. Promulgation of 
restrictive criteria under which DAC assets would not need to be written off will lead to insurance 
enterprises making less than sound economic decisions to protect DAC assets.
Issue 2: Which of the views presented in the Discussion Paper is most appropriate and might 
there be other views that should be considered.
We believe that View B has substantia, merit. While we agree with View C that the replacement of 
contracts with substantially similar terms should not result in a write-off of existing DAC, we would 
go further and say that contracts should be substantially dissimilar before DAC should be written 
off. This is consistent with the conclusion of the ETIF that an exchange of debt instruments with 
substantially different terms is a debt extinguishment. From our perspective, we believe that there 
is a continuation of the basic contractual relationship, and that the real (although intangible) 
economic asset that DAC represents to the enterprise has not been diminished.
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We would define substantially dissimilar, however, very broadly. For example, an annuity contract 
and a universal life contract are substantially dissimilar, while the presumption would be that two 
annuity contracts are not.   
Issue 3: What criteria can be developed for determining whether a replacement is between 
contracts that are substantially similar.
We believe most internal replacements encountered in practice will not involve contracts that are 
substantially similar assuming a narrow definition of substantially similar. Guidance following this 
approach will have a harsh impact on insurance enterprises. Further, having to determine 
whether contracts are substantially similar means the focus will shift to satisfying technical 
requirements and possible gaming, rather that looking to see if fundamental economic 
relationships in a broad sense have been changed. We think the focus ought to be on the 
intangible DAC asset itself. We believe that if the real (although intangible) asset represented by 
DAC on the balance sheet has not been diminished, then it should not be written off.
This is consistent with the perspective that insurance enterprises often view DAC assets at the 
aggregate level as relating to a block of business, not necessarily to individual contracts. If a 
given block of business can continue to support that DAC under recoverability tests, and if those 
original deferred costs are directly linked to  that block  ( which is still the case even where internal 
replacements are involved), then from an economic perspective, writing DAC off is not justified. 
An analogy may be drawn to the intangible asset “goodwill” on a company’s balance sheet. 
Goodwill is not written off even if a company undergoes radical change so long as the company 
has not experienced a loss of value.  
Another inconsistency is that by writing off DAC on an internal replacement, the inference is that 
little, if any, costs were incurred to acquire the replacement contract. This is not the case as most 
of those costs incurred in connection with the replacement contract were in reality incurred with 
the issuance of the first contract. This is particularly true for direct writers, where there are no 
commissions on either the original or replacement contracts.
The use of present values of cash flows to establish similarity between contracts as suggested by 
EITF for debt extinguishments runs into difficulty as applied to insurance products. When 
contracts include embedded options, basic present value techniques need to be expanded. 
Stochastic simulation and option pricing techniques may become necessary to fairly evaluate a 
contract. As an example, a replacement annuity contract providing for a reduction in a guaranteed 
crediting rate offset by an increase in current credited rates should have a different present value 
of future cash flows when compared to a previous contract without these changes under a given 
set of interest rates and other assumptions. However, the. two contracts may actually have the 
same value to the enterprise. One reason for this is tha t the results of cash flow projections are 
influenced by the choice of assumptions ( such as in terest rate scenarios and policyholder 
behavior and their interrelationships) and that frequently the enterprise will evaluate cash flow 
projections over a range of possible assumptions. If the two contracts are tested under a range of 
economic scenarios weighted by the likelihood of occurrence, it may be that overall they would be 
considered economically similar. Using one set of prescribed assumptions may not reflect this.
Issue 4: What costs (if any) should be considered as eligible costs for deferral in a replacement
transaction.
Given a situation where the replacement contract is substantially dissimilar to the original contract 
such that writing off the DAC is justified, we believe the criteria for identifying deferrable costs on 
the replacement contract are the same as for any new contract, and that FASB Nos. 60 and 97 
provide sufficient guidance. For replacement transactions where DAC is not required to be written 
off, additional DAC should be permitted if it meets the FASB Nos. 60 tests and if recoverability 
tests are satisfied.
We appreciate having the opportunity to comment on these issues.
Respectfully,
Ken Vande Vrede, FSA
Cameron, H ines & Hartt
(A Professional Accounting Corporation)
107 Contempo Avenue 
W est Monroe, Louisiana 71291
M ail n g Address:
P. O. Box 2474
West Monroe, LA 7 1 2 9 0 4 7 4
Phone (318) 323 1717 
Fax (318) 322-5121
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September 2 2 ,  1999
Elaine M . Lehnert, Technical Manager
Accounting Standards, File 3162
A ICPA
1211 Avenue o f the Americas
N ew  Y o rk , N Y  10036-8755
VIA FAX
Re: Discussion Paper-Accounting by L ife  Insurance Enterprises For Deferred Acquisition Costs on 
Internal Replacements other than those covered by FASB Statement No. 97.
Date: June 2 5 ,  1999
Response Prepared by: Accounting and Auditing Standards Committee 
Society o f  Louisiana CPA's
Vance R. Balles, CPA, C V A  
John Cameron, CPA  
Bruce Wampler, CPA
The above committee members all agreed that V iew  A  was the most desirable alternative. It  appears to 
be the most conservative approach.
The essential difference between views A  and B relates to whether Deferred Acquisition Cost should 
follow  the contract or the customer. It  seems to us that the costs are associated with the contract, a 
viewpoint that is supported by the fact that selling costs are not capitalized unless a contract results (an 
analogy is successful-efforts accounting for the oil and gas industry). I f  the contract no longer exists, then 
there can be no basis for continuing to cany an asset related to the contract
In  reading V iew  C the E IT F  acknowledged that an exchange on modification in terms that are 
substantially similar did not result in an extinguishment. Considering this, treating an internal 
replacement similar to an extinguishment o f debt would trigger the write o ff  o f  any unamortized deferred 
acquisition costs related to the initial contract.
A  fourth alternative (not mentioned in the Discussion Paper) would be to continue to amortiz e  the D A C  
related to the original contract, but immediately expense all acquisition costs related to the replacement 
contract. U n d e r this approach, the costs associated with the replacement contract are viewed as 
unnecessary, in the sense that they could have been avoided had the insurance company originally sold 
the policyholder the “best”  product. Since these cost are unnecessary, they should not be viewed as an 
asset and should not be capitalized.
Elaine M . Lehnert, Technical Manager 
A IC P A
September 2 2 ,  1999
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One of the key issues appears to be the criteria for determining whether an internal replacement should be 
considered a new contact or a continuation o f the original contract. Also, criteria for determining i f  a 
contract is substantially sim ilar or different should be addressed. U ntil these criteria can be established 
and agreed upon, the accounting treatment o f internal replacements w ithin the L ife  Insurance Industry 
w ill probably remain inconsistent. I t  is important to have consistency within the industry as the public 
evaluates/chooses which company to do business with.
Respectfully,
JO H N  C A M E R O N , CPA  
S O C IE T Y  O F  L O U IS IA N A  C P A ’s 
C O M M IT T E E  M E M B E R
SEP 24 1999 1 5 : 5 3  FR NFS INV REL
ONE NATIONWIDE PLAZA  COLUMBUS, OHIO 43215-2220
6146776688  TO #912125966064 P .0 2 /0 3
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September 2 4 ,  1999
Ms. Elaine M. Lehnert
Technical Manager
Accounting Standards, File 3162
American Institute o f Certified Public Accountants
1211 Avenue o f  the Americas
New York, N Y  10036-8775
Re: Invitation to Comment, Accounting b y  Life Insurance Enterprises f o r  Deferred Acquisition Costs
on Internal R ep la cem en ts  O th er Than Those Covered by FASB Statement No. 97
Dear Ms. Lehnert
Nationwide Financial Services, Inc. (NFS) appreciates the opportunity to provide its comments on the 
AlCPA Discussion Paper, A ccou n tin g  by l i f e  Insurance E n terprises fo r  Deferred A cq u isitio n  Costs on 
In tern al Replacements Other Than Those Covered by FASB Statement No. 97. NFS is the holding 
company for Nationwide Life Insurance Company, the third largest writer o f  individual variable annuity 
contracts in the United States during the year ended December 3 1 ,  1993.
Regarding Issue 1 o f  the Discussion Paper, which requests comments on whether authoritative guidance is 
needed on the accounting by life insurance enterprises for deferred acquisition costs (DAC) on internal 
replacements other than those covered by FASB Statement No. 97, NFS is not aware o f any substantial 
diversity in practice related to this issue that would warrant the development o f  additional authoritative 
guidance. While some diversity surely exists, we do not believe that the comparability o f financial 
statements among life insurance enterprises has been materially affected. In addition, we don’t believe 
inLemal replacement activity has been significant for most insurers.
SEP 24 1999 1 5 :5 3  FR NFS INV REL 6146776688 TO #912125966064 P .0 3 /0 3
Although we believe no additional authoritative guidance is needed at this time, w e would like to take the 
opportunity to provide some comments on View C as described in the Discussion Paper. View C would 
apply the debt extinguishment provisions o f  FASB Statement No. 125 and the guidance for debt exchanges 
and modifications established by EITF No. 96-19 to life insurance product internal replacements. We 
believe the similarity test provisions o f this view  have some merit; however, i f  it is decided that guidance 
should be developed for internal replacement transactions, we would like to see the provisions of this view  
described and reviewed in more detail before a final method is selected. Specifically, w e would 
recommend further details be provided as to how the 10 percent test to determine i f  insurance contracts are 
substantially different would be applied in practice. For instance, it would bo helpful to know exactly what 
cash flows would apply to the test, c.g. only cashflows between the insurance provider and the customer or 
also include cash flows with third parties, such as distributors and mutual fu nd houses. Also, due to the 
significant nature o f some third party payments in many internal replacement transactions we believe that 
capitalization o f  those payments in addition to the unamortized DAC on the original contract would be 
appropriate i f  the contacts are not determined to be substantially different This is inconsistent with EITF 
No. 96-19 which requires that all costs incurred with third parties be expensed as incurred i f  a replacement 
debt instrument is not substantially different from the original.
Again, NFS appreciates the opportunity to comment on this issue and looks forward to reviewing the 
results o f the comment period. We would be pleased to discuss our comments with the AICPA or its staff 
at their convenience.
Sincerely,
David A. Jacoby  
Associate Vice President — Controller 
Nationwide Financial
* *  TOTAL PAGE.03  * *
September 24, 1999
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Elaine M. Lehnert, Technical Manager
Accounting Standards, File 3162
American Institute of Certified Public Accountants
1211 Avenue of the Americas
New York, NY 10036-8775
RE: Comments on Discussion Paper, Accounting by Life Insurance Enterprises for 
Deferred Acquisition Costs on Internal Replacements Other Than Those Covered by 
FASB Statement No. 97
Dear Ms. Lehnert:
Minnesota Life appreciates the opportunity to comment on the above discussion paper 
prepared by the Insurance Companies Committee of the AICPA. We offer the following 
comments to the first three issues presented in the discussion paper.
1. W hether authoritative guidance is needed on the accounting  by life  insurance  
enterprises for deferred acquisitions costs (D A C ) in situations characterized  as 
internal replacem ents.
We believe authoritative guidance is needed, and support the Committee's efforts to bring 
uniformity to the reporting of internal replacements.
2. W hich  o f  the view s presented herein  is m ost appropriate and w h eth er  there are  
other v iew s that should be considered.
We support View C, which recognizes that the replacement of one insurance/investment 
contract with another contract with substantially similar terms should not result in a 
write-off of any unamortized DAC related to the initial contract.
We recognize the Board's position in FASB Statement No. 97 concerning replacements of 
traditional life contracts by universal life-type contracts. We also recognize the Board did 
not accept the argument that the replacement contract represented a continuing 
relationship between the insurer and the policyholder, and therefore, the new contract 
represented only a change in the form of insurance protection.
However, Minnesota Life has a long-standing position of offering policy exchanges on a 
favorable basis to ensure existing policyholders are treated equitably in comparison to 
new policyholders. Therefore, we attempt to make new products available to existing 
policyholders, on an internal replacement basis, at a minimal cost with no commissions 
paid on the transaction. As a consequence, we have a high percentage of our 
policyholders that choose to switch to new products when they are introduced. In most
cases, the internal replacement does not change the nature of the agreement between the 
policyholder and Minnesota Life.
Further, we consider internal replacements among Minnesota Life’s Adjustable products 
to be unique from the industry treatment of internal replacements among universal life 
products. When a contract is exchanged for another contract, Minnesota Life has 
consistently treated the policyholder as if they were continuing the same contract. No 
additional compensation is paid on the new contract. From an administrative standpoint, 
the contract's original issue date is preserved; no changes are made to the duration 
considerations in the contract (i.e., the contract remains at the same point in scale). The 
select period for mortality charges is not reset, the contract year for compensation 
purposes is not reset, and the lapse duration for projections is not reset. For all practical 
purposes, Minnesota Life expects the new contract to act as if it were issued at the same 
time as the old contract. Thus, we not only treat the old and new contracts as 
substantially similar, we treat the new contract as if it were a continuation of the exact 
same contract.
We support the proposal to treat policies differently depending on whether or not they are 
substantially similar to new products.
3. W hat criteria can be developed for determ in ing w hether a rep lacem ent is 
betw een contracts that are substantia lly  sim ilar.
We support the development of objective criteria as a means to promote consistency in 
the reporting of these transactions in practice. We request the Committee to explore the 
following criteria:
■ no or reduced underwriting effort related to the new contract unless the face amount 
on the new contract is higher than the face amount of the original contract.
■ no additional commission paid on the continuing premiums above the old point in 
scale.
■ future assumptions in the projection of gross profits similar to the old contract.
■ no significant expected changes in persistency and other experience.
■ no additional charges on the replacement transaction.
Again, thank you for the opportunity to comment. If you have any questions or would 
like to discuss our comments further, please don't hesitate to contact me at 651-665-4122 
or david.leplavy@minnesotamutual.com.
Sincerely,
David J. LePlavy
Assistant Controller
SEP-28-1999 10:17 RELIASTAR 612 342 3966 P .02 /04
Jam es R. M iller
Senior Vice President,
Chief Financial Officer and Treasurer
Phone (612) 342-3476
Fax (612) 342-3966
RELIASTAR
ReliaStar Financial C orp. 
20 Washington Avenue South 
Minneapolis, MN 55401
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September 25, 1999
Ms. Elaine M . Lehnert
Technical Manager
Accounting Standards, File 3162
American Institute of Certified Public Accountants
1211 Avenue o f the Americas
N ew  York, N Y  10036-8775
Re: Invitation to Comment, A ccou n tin g  b y  L ife Insurance Enterprises f o r  D eferred  A cqu isition  C osts
on Internal Replacements Other Than Those Covered by FASB Statement No. 97
Dear Ms. Lehnert:
R eliaStar Financial Corp. appreciates the opportunity to comment about accounting for internal 
replacements. Following is our response to the six issues presented in your Discussion Paper.
Issue 1: Is authoritative guidance needed on the accounting by life insurance enterprises fo r deferred 
acquisition costs (D A C ) in situations characterized as internal replacements?
We believe guidance is needed to promote consistency o f practice. Current guidance allows but does not 
require carry-over amounts in certain internal replacement situations, which may create diversity in 
practice. Current guidance is also not specific as to the circumstances that would allow carry-over o f  
amounts. Paragraph 26 o f SFAS 97 explicitly prohibits the carry-over o f amounts associated with an 
internal replacement o f a traditional life insurance contract with a universal life-type contract. Paragraph 
.19 o f Practice Bulletin 8 emphasizes that SFAS 97 addresses only replacement o f traditional insurance 
contracts by universal life-type contracts. I t  also provides no elaboration on the rationale in SFAS 97 but 
indicates that "the accounting for other internal replacements should be based on the circumstances o f the 
transaction” .
Issue 2: W hich o f the views presented herein is most appropriate? Are there other views that should 
be considered?
We support the conclusion that continued deferral o f DAC may be sometimes appropriate, which is 
allowed under varying circumstances under Views B o f the Discussion Paper. W e believe that the 
prohibition o f deferral in  V iew  A  is not consistent with existing accounting guidance and is not 
appropriate.
Both V iew B and V iew  C o f the Discussion Paper conclude that continued deferral o f D A C  may be 
sometimes appropriate. The difference between the two views hinges on the criteria for eligibility o f  
deferral treatm ent.
W e support V iew  B. V iew  B is consistent with the position th a t the in ternal rep lacem en t transaction 
represents a continuation of a contractual relationship between the insurer and the insured. We believe the 
carry-over o f amounts under View B is appropriate because:
•  An internal replacement program is generally designed to preserve or improve the ongoing economics
o f the customer relationship.
SEP-28-1999 10:17 RELIASTAR 612 342 3966 P .03 /0 4
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•  The ability to cany-over amounts in a replacement situation creates an accounting model consistent 
with the economic motives o f the replacement A  reported GAAP loss in the period that the 
relationship with the customer has been changed or extended is inconsistent with the economic result 
o f the transaction.
•  The flexibility o f today’s insurance contracts already allows modification o f the company-customer 
relationship. A  replacement may be a more visible modification, but in substance can often be similar 
to flexible transactions allowed within a contract.
View C looks to the terms o f the initial and replacement contracts as the chief criteria for eligibility for 
deferral o f D AC . Debt instruments, which serve as the replacement model for V iew  C, have markedly 
different underlying obligations and risks compared to those in insurance contracts. Consequently, we 
believe the guidance relating to debt Instruments would be inappropriate to insurance replacement 
transactions.
View A  o f the Discussion Paper appears to be internally inconsistent Paragraph 8 indicates that the write­
o ff o f costs should be extended by analogy to all types o f replacements, which we interpret as no 
opportunity to carry-over amounts in any situation. Paragraph 10, however, suggests that the FASB’s 
restriction in Statement 97 was appropriate to the products then under discussion, and may not be reflective 
o f the FASB’s views on other kinds o f replacements. We interpret this statement to suggest there may be 
situations where carry-over is appropriate.
Issue 3: W h at criteria can be developed for determining whether a replacement is between contracts
that are substantially similar?
•  As stated above in Issue 2, we do not agree with V iew  C.
Issue 4: W h a t costs ( i f  any) should be considered as eligible costs fo r deferral in a replacement 
transaction?
Eligible costs may include:
•  Costs which meet the criteria for deferral under current accounting guidance.
•  The unamortized portion o f  deferred acquisition costs o f  the replaced contract
•  The difference between the replaced contract’s GAAP benefit reserve and the cash value transferred 
(which may include waiver o f a surrender charge).
The sum o f  the second and third amounts may result in deferral o f a gain or loss, depending on the 
relationship o f  the net G A A P reserve o f the replaced contract to the transferred cash value.
Any amounts deferred should be subject to the usual test o f recoverability. More stringent tests might be 
recommended such as:
•  The total amounts deferred could be limited to an amount that would otherwise be deferred on a 
similarly issued new contract
•  A lte rn a t iv e ly ,  a lim it to total amounts deferred could be made such that the newly replaced contract 
has a profitability profile no less than that o f a similar, newly issued contract. In other words, total 
a m o u n ts  deferred may be further limited due to other factors, such as the impact on mortality margin
SEP-28-1999 10:18 RELIASTAR 612 342 3966 P .04 /0 4
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in a replacement situation where no underwriting is done.
Issue 5: W h a t other issues or practical considerations should be examined related to this topic?
Guidance is needed to more clearly define the conditions that create a replacement contract Some criteria 
might include:
•  T h e  presence o f an “inter-contract” transaction, that is, one contract funds the issuance o f another 
contract.
•  The level o f commissions or other acquisition costs incurred on the replacement contract relative to  a  
similarly issued new contract -  reduced levels o f acquisition costs may suggest a replacement contract.
•  The existence o f marketing programs such as an offer limited to existing policyholders only.
•  Underwriting concessions or simplifications in the replacement contract.
•  Forces that generated the replacement. Should there be accounting differentiation between a contract 
that was replaced due to internal forces (such as an internal replacement program sponsored by the 
insurance company) and one that was replaced due to external forces (such as an agent rewriting an 
existing contract to a different product with full agent compensation and full policyholder 
underwriting requirements)?
Accounting for carry-over amounts m ay create practical valuation issues. For example:
•  D  AC is often valued on a block o f business, rather than seriatim by contract. Some guidance may be 
needed as to how to allocate unamortized DAC  among contracts for the purposes o f determining carry­
over amounts.
•  The ability to track replacement contracts m ay be difficult, unless they are a result o f a “replacement 
program” developed by an insurance company.
•  Guidance w ill be necessary on the treatment o f historical profit margins in the amortization o f products 
that arc subject to ongoing unlocking due to experience (SFAS 97 investment and universal life 
contracts, and SOP 95-1 participating contracts). Should the change in profit expectations be reflected 
in a prospective fashion only? Practically, few companies capture estimated profit margins at the 
policy level. Valuation alternatives may include an amortization approach that commingles the actual 
profit margins o f the replaced product with the expected profit margins o f the replacement product
Issue 6; The Insurance Companies Committee would like to further investigate the analogy between 
internal replacements and modification or exchanges o f debt instruments....
Please see the related discussion under Issue 3 and Issue 4.
Thank-you for the opportunity to comment
Sincerely,
James R. M iller, FSA, M A A A
Arthur Andersen LLP 6
September 24, 1999
Ms. Elaine M. Lehnert 
Technical Manager 
Accounting Standards 
File 3162 
AICPA
1211 Avenue of the Americas 
New York, NY 10036-8775
Dear Ms. Lehnert:
We are pleased to have the opportunity to respond to the Discussion Paper, Accounting by Life Insurance 
Enterprises for Deferred Acquisition Costs on Internal Replacements Other Than Those Covered by FASB 
Statement No. 97 (the "Paper"). Our summary comments are followed by responses to the specific issues 
posed by the AICPA's Insurance Companies Committee (the "ICC").
Summary Comments
We believe that authoritative guidance is needed and recommend that the ICC assign a project team to 
draft a prospectus to develop a Statement of Position or Practice Bulletin. We agree with the concept 
presented in View C; however, we are concerned with a methodology based on the present value of 
future cash flows. The use of future cash flows for debt may be appropriate, but it is not necessarily 
appropriate for insurance products. We suggest that the determination of "substantially different" be 
based first, on the product or class of product, and second, on the present value of estimated gross profits, 
a concept and model already in practice.
Comments on Specific Issues
Issue 1. Whether authoritative guidance is needed on the accounting by life insurance enterprises for 
deferred acquisition costs (DAC) in situations characterized as internal replacements.
Authoritative guidance is needed. Since the issuance of Statement on Financial Accounting Standards 
("SFAS") No. 97, Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and 
for Realized Gains and Losses from the Sale o f Investments ("SFAS 97") in 1987, there has been a substantial 
increase in the issuance of non-traditional insurance and investment-type products. Competitive 
pressures and the rapid development of new products and new product features have resulted in 
insurance enterprises seeking to convert existing policies to updated policies to counter a loss of business 
or to retain an existing policy base. For example, many life insurance enterprises sell investment products 
with a surrender charge. The surrender charge is a mechanism by which the insurance company can 
recover sales and installation costs in the event a policyholder surrenders his/her contract during the 
early years of its existence (historically seven years, with the charge decreasing over that period). As 
policyholders near the end of or eclipse the surrender period, sellers of investment products may attempt
6
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to convert a policyholder to a similar, but updated product with new features, at a different company. 
Existing literature, namely SFAS 97, and Practice Bulletin 8, Application o f  FASB Statement No. 97, 
Accounting and Reporting by Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains 
and Losses from the Sale o f Investments ("PB 8"), address only internal replacements of a traditional life 
insurance contract by a universal life insurance contract. Paragraph 26 of SFAS 97 is silent with respect to 
internal replacements other than universal life for traditional life. Paragraph 19 of PB 8 provides only 
little additional guidance, as it states, "the accounting for other internal replacements (other than 
universal for traditional) should be based on the circumstances of the transaction." Furthermore, in the 
basis for conclusion section of SFAS 97 (paragraph 72), the Financial Accounting Standards Board (the 
"Board") clearly analogizes internal replacements to an "extinguishment of debt" accounting model that 
has since been modified by Emerging Issues Task Force ("EITF") Issue 96-19, Debtor's Accounting for a 
Modification or Exchange of Debt Instruments ("EITF 96-19"). Due to the limited guidance in the existing 
literature and the proliferation of insurance/investment contracts, insurance enterprises are left to devise 
their own accounting policies, which results in diversity in practice.
Issue 2. Which of the views presented herein is most appropriate and whether there are other views 
that should be considered.
We believe that View C is the most appropriate. As mentioned in response to Issue 1, paragraph 72 of 
SFAS 97 states, "The Board recognizes that an insurance enterprise that conducts an internal replacement 
program may be motivated by a desire to retain its customer base and that the alternative to replacement 
may be the loss of that base. The objective is not, however, different from the objectives of similar 
transactions undertaken by insurance enterprises and other enterprises for which continued deferral of 
costs is not permitted, including the refunding of debt." Paragraph 72 refers to Accounting Principles 
Board Opinion No. 26, Early Extinguishment o f Debt, as amended by FASB Statement No. 76,
Extinguishment o f Debt ("SFAS 76"), as the governing literature, which requires the write-off of 
unamortized costs associated with extinguished debt when the extinguished debt is relieved by a new 
liability to the same party. EITF 96-19 interprets the guidance presented in SFAS 76 to reflect that certain 
debt exchanges do not contain substantive modifications to the existing debt, resulting in unamortized 
amounts related to the old debt, and new fees exchanged between the parties related to the new debt, 
being amortized over the life of the new debt. However, costs paid to third-parties, as part of the 
replacement, would still be expensed as incurred. Therefore, the conclusions drawn by the Board as it 
relates to internal replacements could be interpreted similarly. As such, the concepts presented in View 
C, which analogize to the guidance contained in EITF 96-19, are the most appropriate.
View A is inappropriate because it is not supported by an existing accounting model (EITF 96-19 replaced 
the model upon which View A is built). View B also is inappropriate because, as part of the deliberations 
leading to Statement 97, the Board rejected an AICPA Issues Paper that suggested the "continuing 
relationship" concept.
Paragraphs 12 and 13 of SFAS No. 91, Accounting for Nonrefundable Fees and Costs Associated with 
Originating or Acquiring Loans and Initial Direct Costs o f Leases (An Amendment o f  FASB Statements No. 13, 60, 
and 65 and a Rescission o f  FASB Statement No. 17) ("SFAS 91"), suggest an alternative accounting model 
related to internal replacements which might be considered. In summary, those paragraphs state that,
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from the lender's perspective, when a loan is refinanced with terms at least as favorable to the lender as 
terms for comparable loans currently offered to other customers with similar collection risks who are not 
refinancing, the loan shall be accounted for as a new loan, requiring the recognition in the income 
statement of any unamortized fees or costs. "Comparable terms" is defined as at least an equal effective 
yield of the new loan to currently offered loans. If that condition is not met, the unamortized fees and any 
penalties are carried forward. This model suggests, similar to View C, that circumstances might exist 
where unamortized balances are not taken into earnings.
EITF Issue 98-14, Debtor's Accounting for Changes in Line-of-Credit or Revolving-Debt Arrangement (EITF 98- 
14), further supports the concepts presented in View C. EITF 98-14 developed a model for determining 
whether modifications to line of credit or revolving debt agreements resulted in a new debt agreement. 
The model presented by EITF 98-14 is defined as the "borrowing capacity" of the agreement. "Borrowing 
capacity" is defined as the product of the term or remaining term of the agreement and the maximum 
available credit. If the "borrowing capacity" of the new arrangement is greater than or equal to the 
"borrowing capacity" of the old arrangement, the EITF states that, "any unamortized deferred costs, any 
fees paid to the creditor and any third-party costs incurred should be associated with the new 
arrangement (that is, deferred and amortized over the term of the new arrangement)".
Issue 3. What criteria can be developed for determining whether a replacement is between contracts 
that are substantially similar.
EITF 96-19 suggests that the present value of cash flows is the appropriate criterion, for debt instruments, 
in determining debt contracts that are substantially similar. As discussed in our Summary Comments 
above, determining future cash flows on a debt instrument is much simpler and easier to apply in practice 
due to the fixed terms and payments generally accompanying debt instruments. Insurance contracts tend 
to be more complex, with fixed or variable terms, fixed or variable payments, embedded optionality and 
uncertainty with respect to the timing of payments. The complexity and uncertainty associated with 
insurance contracts does not lend itself to the use of cash flows as the criterion for determining contracts 
which are substantially similar. Furthermore, debt instruments generally are replaced by another debt 
instrument of similar terms. Insurance contracts can be replaced by new contracts of similar terms, but 
may also be replaced by insurance contracts with very different terms. The differences in the types of 
insurance contracts or products is not contemplated by EITF 96-19.
We recommend the criteria presented in the following decision tree be considered as an appropriate 
model for determining whether two insurance contracts are substantially similar. The decision tree 
focuses first on whether the original contract is being replaced by a contract that is opposite in duration 
(short vs. long as defined by SFAS No. 60, Accounting and Reporting by Insurance Enterprises ("SFAS 60")). 
We believe the differences between a long and short duration contract constitute a substantially different 
contract. If a long duration contract is replaced by a long duration contract, SFAS 97 defines classes of 
contracts which could be considered substantially different. For example, a universal life contract 
replaced by an investment contract would constitute substantially different contracts. If the new contract 
is of the same class and duration as the original contract, we believe a difference of greater than 10% in 
discounted estimated gross profits, as defined by SFAS 97, similar to EITF 96-19, indicate the contracts are 
substantially different. If the original contract is an investment contract or universal life-type contract, as
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defined by SFAS 97, then the estimated gross profits to be used for the original contract should be the 
same as those used in the current deferred acquisition cost amortization schedule for that contract. The 
new contract's estimated gross profits should be determined consistent with the requirements of 
paragraph 23 of SFAS 97. (Note that the decision tree presumes that the policyholder does not change. If 
the policyholder changes, the replacement would be substantially different.)
Is the contract a 
short term contract 
being replaced by
a long term 
contract or vice 
versa?
Yes
Replacement is 
substantially 
different.
No
Is the original contract 
a long or short 
duration contract?
Short
Short term contracts replaced by 
short term contracts generally occur 
at the end of a contract term, at 
which point all deferred acquisition 
costs would be fully amortized.
Long
SFAS 97 defines three classes of long 
duration contracts. Is the new contract 
of a different class than the original 
contract?
Yes
No
Is the discounted estimated gross profits of 
the replacement contract different from the 
discounted initial gross profits of the original
contract by more than 10%?
 Yes
No
Contracts are 
substantially 
similar.
Page 5
September 24 , 1999
Issue 4. What costs (if any) should be considered as eligible costs for deferral in a replacement 
transaction.
Costs eligible for deferral in acquiring an insurance contract are defined and described in paragraph 28 of 
SFAS 60 and paragraph 24 of SFAS 97. Paragraph 28 of SFAS 60 states, "Acquisition costs are those costs 
that vary with and are primarily related to the acquisition of new and renewal insurance contracts. 
Commissions and other costs (for example, salaries of certain employees involved in the underwriting 
and policy issue functions, and medical and inspection fees) that are primarily related to insurance 
contracts issued or renewed during the period in which the costs are incurred shall be considered 
acquisition costs." Paragraph 24 of SFAS 97 adds, "Acquisition costs that vary in a constant relationship 
to premiums or insurance in force, are recurring in nature, or tend to be incurred in a level amount from 
period to period shall be charged to expense in the period incurred." Given these definitions, we 
interpret replacements to be analogous to renewals; therefore, costs meeting the deferral requirements of 
SFAS 60 and SFAS 97 would be eligible for deferral in an internal replacement transaction. We would not 
expect any changes or expansion to these definitions.
EITF 96-19 describes that fees paid by the debtor to the creditor, or received by the debtor from the 
creditor in a non-debt extinguishment situation, "are to be associated with the replacement or modified 
debt instrument and, along with any existing unamortized premium or discount, amortized as an 
adjustment of interest expense over the remaining term of the replacement or modified debt instrument 
using the interest method." The EITF further states that costs incurred with third parties, in a non-debt 
extinguishment situation, "should be expensed as incurred". This notion seems inconsistent, however, 
with SFAS 60's definition of acquisition costs and their deferral. An internal replacement could be 
analogous to a renewal and therefore costs incurred with third parties, namely agents, in a replacement, 
would be deferred in accordance with paragraphs 28 and 29 of SFAS 60. A further inconsistency is 
described in our response to Issue 3. EITF 98-14, in certain situations, allows deferral of the unamortized 
costs of the "old" line-of-credit and allows deferral of costs incurred with third parties in connection with 
modifications or exchanges of a line-of-credit or a revolving-debt arrangement. Additionally, since the 
amortization method is defined, for DAC, by SFAS 97 or SFAS 60, those methods would be more 
appropriate than the interest method suggested in EITF 96-19.
We recognize that under our proposed approach it would be possible to capitalize two layers of DAC 
with respect to a replacement that is considered substantially similar. Under EITF 96-19, by contrast, it 
would not be possible to capitalize two layers of debt issuance costs for a replacement that is considered 
substantially similar. We believe this different result is supportable based on the provision in Statement 
60 requiring capitalization of DAC for renewals. Under Statement 60, a renewal commission might be 
paid and capitalized in addition to unamortized DAC from the original issuance.
Issue 5. What other issues or practical considerations should be examined related to this topic.
Generally, acquisition costs associated with investment contracts or universal life-type contracts are 
aggregated by block of business, plan code or issue year, not on an individual contract by contract basis. 
This record keeping presents the most challenging consideration with respect to implementing an internal 
replacement model as described in our response to Issue 3. If acquisition costs were tracked on an
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individual by individual contract basis, like costs associated with debt instruments, it would be easy to 
identify costs associated with a replaced contract and be able to carry those costs to the new contract. 
Since acquisition costs are aggregated, replacement situations to date, where costs associated with the old 
contract are written off, result in an adjustment to the DAC amortization model for the actual experience 
of a "surrender", in effect. The new contract becomes part of an aggregation of newly issued insurance 
contracts. In an internal replacement situation, where the DAC associated with the original contract is to 
be carried to the new contract, the impact to the original contract's amortization model from a 
replacement or "surrender" would need to be calculated or modeled separately from other actual activity 
during the year. This separate calculation should result in the identification of the remaining 
unamortized DAC to be included in the new contract's aggregated DAC asset.
Issue 6. The Insurance Companies Committee would like to further investigate the analogy between 
internal replacements and modification or exchanges of debt instruments as it relates 
to deferral of costs (see View C). To do that, the following areas need further 
exploration.
• What are the criteria that should be used to measure whether an internal 
replacement is between contracts that are substantially similar (or different)?
• If an internal replacement is between contracts that are substantially 
similar, what costs should be deferred? If commissions paid to agents or brokers are 
incurred, is it appropriate to defer those in light of the guidance in EITF 96-19.
We refer you to our responses, comments and thoughts on these issues in our responses to Issues 3 and 4.
We would be pleased to discuss our comments with the ICC, a developed task force or AcSEC at their 
convenience.
Very truly yours,
09/29/1999 11:04 2026242172 ACLI PAGE 01
American Council of Life Insurance
Stanton L . Cole 
Actuary
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September 2 9 ,  1999
Ms. Elaine M. Lehnert
Technical Manager
Accounting Standards, File 3162
American Institute o f  Certified Public Accountants
1211 Avenue o f the Americas
New York, NY 10036-8775
Re: Invitation to Comment, Accounting by Life Insurance Enterprises fo r  D eferred
Acquisition Costs on Internal Replacements Other Than Those Covered by FASB Statement No. 97
Dear Ms. Lehnert:
The Generally Accepted Accounting Principles Committee (the Committee) o f  the American Council o f  
Life Insurance (ACLI) appreciates the opportunity to provide its comments about the above Invitation to 
Comment. The ACLI is the principal trade association o f life insurance companies, and its 493 members 
represent, in the aggregate, 82.3 percent o f the assets o f  all domestic life insurers.
With respect to whether accounting guidance is needed on accounting by life insurance enterprises for 
deferred acquisition costs (DAC) on internal replacements other than those covered by FASB Statement 
No. 97, the Committee believes that while some diversity in practice exists, it is unaware o f any significant 
problems related to such diversity. Accordingly, we do cot see the need for any additional guidance at this 
time. If guidance were to be developed, however, we would disagree with any position that would always 
require the write-off o f existing unamortized DAC in cases o f  internal replacements.
Rather, we believe that there are circumstances where it might be appropriate to retain the unamortized 
DAC related to the original contract based on an evaluation o f the specific terms o f  the contracts and 
whether recoverability tests are m et
We thank you for giving the Committee the opportunity to comment on the Invitation to Comment and 
would be pleased to discuss our comments with the AICPA or its staff at their convenience.
Sincerely,
Stanton L. Cole
SLC:jmb
1001 PENNSYLVANIA AVENUE, N.W. 
WASHINGTON, D.C. 20004-2599  
202 /624-2164  •  FACSIMILE 202 /524-2319  
TDD 202/624-2090
Author: MIME:TODDH@hascal.com at INTERNET
D a t e : 9 / 2 3 / 9 9  4 : 4 8  PM
Priority: Normal
TO : E l a i n e  M. L e h n e r t  a t  A ICPA 3
Subject: Discussion Paper re FASB No. 97
Dear Elaine-
We have read and discussed this paper. Although the members of our committee 
do not have the expertise regarding the insurance industry to comment as you 
would have liked, we did want to respond as follows.
Based on issues the Insurance Companies Committee wants comments on and the 
various view points offered for discussion, it appears to us that there is a 
need to provide standards for replacements beyond the narrow constraints of 
FASB 97, ie universal life policies.
Todd H. Hangen, CPA
Member of the Washington State Society
Accounting, Auditing and Review Standards Committee
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Ms. Elaine M. Lehnert
PricewaterhouseCoopers LLP
500 Campus Drive 
P.O. Box 805 
Florham Park NJ 07932 
Telephone (973) 236 7000 
Facsimile (973) 236 7200
Technical Manager
Accounting Standards, File 3162
American Institute of Certified Public Accountants
1211 Avenue of the Americas
New York, NY 10036-8775
Re: Comments on the Discussion Paper, Accounting by Life Insurance Enterprises for 
Deferred Acquisition Costs on Internal Replacements Other Than Those Covered by 
FASB Statement No. 97
Dear Ms. Lehnert:
PricewaterhouseCoopers LLP (PwC) appreciates the opportunity to comment on the 
Insurance Companies Committee of the American Institute of Certified Public 
Accountants’ (“the Committee”) discussion paper concerning Accounting by Life 
Insurance Enterprises for Deferred Acquisition Costs on Internal Replacements Other 
Than Those Covered by FASB Statement No. 97 (“the paper”).
We support the Committee’s effort to explore the need for additional authoritative 
guidance regarding the treatment of deferred acquisition costs on internal replacements 
other than those addressed by FASB Statement No. 97, Accounting and Reporting by 
Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and 
Losses from the Sale o f Investments.
Attached are our responses to the issues raised in the paper.
*****
We appreciate the opportunity to express our views. If you have any questions regarding 
our comments, please feel free to contact Donald Doran at (973)236 7214 or 
Mary Saslow at (860) 240 2036.
Sincerely,
PricewaterhouseCoopers LLP
PriCewATeRHOUsecOOPERS  
Whether authoritative guidance is needed on the accounting by life insurance enterprises 
for deferred acquisition costs (DAC) in situations characterized as internal replacements.
We believe that there is a need for additional guidance on accounting for the deferral of 
DAC on internal replacements. AICPA Accounting Standards Division Practice 
Bulletin 8 (PB-8), Application o f FASB Statement No. 97, Accounting and Reporting by 
Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and 
Losses from the Sale o f Investments, to Insurance Enterprises, specifically states that 
FASB Statement No. 97 only addresses the replacement of a traditional life insurance 
policy with a universal life policy. FASB Statement No. 97 does not address accounting 
for such internal replacements as a universal life type policy for another universal life 
type policy, Statement of Position 95-1 (SOP 95-1), Accounting for Certain Insurance 
Activities o f Mutual Life Insurance Enterprises, policies to FASB Statement No. 60, 
Accounting and Reporting by Insurance Enterprises, policies, or the replacement of an 
investment type annuity with another investment type-product. In regard to these other 
types of replacements, PB-8 merely states “the accounting for other internal replacements 
should be based upon the circumstances of the transaction.” This guidance is vague and 
has led to diversity in accounting policies and financial results. We believe that this 
diversity would be mitigated through additional guidance on the accounting for internal 
replacements under generally accepted accounting principles (GAAP).
Issue 2:
Which o f the views presented herein is most appropriate and whether there are other 
views that should be considered.
We do not believe that View A is the most appropriate as we believe that there may be 
certain situations where the continued deferral of remaining DAC on the old policy after 
the replacement may be appropriate. View A would not permit a deferral in any 
situation.
We do not believe that there is any GAAP precedence for View B. The Financial 
Accounting Standards Board rejected the concept of DAC representing customer 
relationships in paragraphs 70 through 72 of FASB Statement No. 97. DAC represents 
the acquisition costs of a contract. While we can see the logic for the continual deferral 
of original costs when one policy is replaced by a policy that is substantially the same in 
form, risk and coverage, we believe that original costs should be expensed at the time the 
original policy is replaced by a contract that is substantially different (i.e., produces 
significantly different economic results) than the original policy.
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We believe that View C is the most appropriate method for addressing the deferral of 
original DAC on replacement contracts. As a life insurance product is similar to a 
long-term liability (i.e., the insurance company has a long-term obligation to a third 
party), we believe that guidance provided in FASB Statement No. 125, Accounting for 
Transfers and Servicing o f Financial Assets and Extinguishments o f Liabilities, and 
Emerging Issues Task Force Issue No. 96-19 (EITF 96-19), Debtor’s Accounting for a 
Modification or Exchange o f Debt Instruments, concerning the exchange of debt in a 
nontroubled debt situation can be used as the basis for developing GAAP accounting for 
replacement contracts.
Consistent with the guidance for debt extinguishment contained in EITF 96-19, we 
believe that it would be appropriate, assuming recoverability tests have been met, for 
original DAC to continue to be deferred when the original policy is replaced by a policy 
that is substantially similar to the contract being replaced. However, we believe that 
original DAC should be expensed currently if the replacement contract is substantially 
different than the contract being replaced.
Issue 3:
What criteria can be developed for determining whether a replacement is between 
contracts that are substantially similar.
The nature of the coverage provided. Does the policyholder receive the same type of 
benefit under both contracts (e.g., a replacement of a life insurance policy to one which 
provides long-term care should automatically be considered “substantially different”)?
The economics of the contract. Is the insurer in a substantially different economic 
position as a result of the new contract compared to the old? This would require a 
definition and criteria for “substantially different” as well as agreement to the appropriate 
“economics” that should be used as a benchmark. If the types of margins, such as 
investment, mortality, or expense, have shifted between the policyholder and the 
insurance company, then that could be an indicator of “substantially different”.
The accounting for the contract. Is a FASB Statement No. 97 contract being replaced 
with a FASB Statement No. 60 contract? We believe that if existing GAAP accounting 
already requires different GAAP treatment for the two policies, then that replacement 
automatically defaults to “substantially different.”
If the above three criteria for being “substantially similar” are met, then a 10% present 
value cash flow test, similar to that prescribed by EITF 96-19, should be applied to the 
cash flows between the insurance company and the policyholder for determining 
“substantially similar.”
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Issue 4:
What costs (if any) should be considered as eligible costs for deferral in a replacement 
transaction.
The costs deferred should depend upon the nature of the contract. If the product qualifies 
for accounting under FASB Statement No. 60 then the costs that vary with and are 
primarily related to the acquisition of the replacement contract (e.g., commissions, 
underwriting costs, and any other costs incurred to replace the old contract with the new) 
should be deferred. If the new contract falls under the accounting provisions of FASB 
Statement No. 97, then the same type of acquisition costs as described in FASB 
Statement No. 60 should be deferred except for those costs that “vary in constant 
relationship to premiums or insurance in force, are recurring in nature, or tend to be 
incurred in a level amount.”
Unamortized DAC associated with an original policy replaced by a contract that is 
substantially similar to the original contract should also continue to be deferred in 
addition to DAC associated with the replacement contract.
Issue 5:
What other issues or practical considerations should be examined related to this topic.
If a replacement contract is deemed to be substantially similar to the original, then what is 
the proper period over which the original DAC should be amortized? Is it appropriate to 
amortize the original DAC over the entire period of the new contract or should the old 
DAC continue to be amortized over the period of the original contract?
If a replacement contract is deemed to be significantly similar to the original contract, 
then DAC associated with the replacement contract along with any existing DAC should 
be amortized over the period covered by the replacement contract. Following the rational 
that a “substantially similar” replacement contract is really just a modification of the old 
contract, then the change in the amortization period should be treated as a change in 
estimate under the provisions of Accounting Principles Board Opinion No. 20, 
Accounting Changes. Accordingly, we believe that it would be appropriate to amortize 
remaining original DAC over the new policy period for FASB Statement No. 97 
contracts. If the original contract is a FASB Statement No. 60 contract, however, DAC 
must continue to be amortized over the original contract period due to the “locking” of 
the persistency assumptions in FASB Statement No. 60 contracts.
For some products, DAC is calculated on the book of business. Is it practical to reduce 
DAC down to the policy level?
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If it is determined that an internal replacement to a FASB Statement No. 60 product 
qualifies for substantially similar contract treatment and unamortized DAC is kept on the 
books, should the entire transaction be considered a continuation of the original contract 
and no premium revenue recognized for the transaction unless new cash is received in the 
year? We believe that if DAC is carried forward, then the entire transaction should be 
treated consistently, that is, premium revenue should not be recognized unless new cash 
is received at the time the replacement contract is issued.
There may be a need to clarify that a conversion in accordance with terms of the original 
contract would not be considered a replacement and should not be treated as a new sale. 
Existing DAC should remain on the balance sheet and premium revenue not be 
recognized for the transaction unless new cash is received at the time the replacement is 
issued.
In regard to the analogy between internal replacements and modification or exchanges o f 
debt instruments as it relates to deferral o f costs:
Issue 6a:
What are the criteria that should be used to measure whether an internal replacement is 
between contracts that are substantially similar (or different)?
We believe that further investigation into the nature and economics of the replacement 
used to evaluate an insurance contract may be warranted. There should be consideration 
of the various risks assumed by the policyholder and the insurance company (such as 
investment, mortality or expense), both before and after the replacement. If these criteria 
are met, then we believe that the present value cash flow approach described in 
EITF 96-19 would be a good tool for evaluating whether an internal replacement is 
substantially similar to or different from the replaced contract. We understand there is 
diversity in opinions on whether, due to the inherent differences between a debt 
agreement and an insurance contract as well as the differences in the relationships 
between the parties involved, the model and 10% criteria established for determining 
whether a debt instrument exchange involves substantially different products is 
appropriate for evaluating insurance replacement contracts. There may be a need to 
provide guidance on the application of the 10% criteria when investment risk is assumed 
by the policyholder.
Issue 6 b:
I f  an internal replacement is between contracts that are substantially similar, what costs 
should be deferred? I f  commissions paid to agents or brokers are incurred, is it 
appropriate to defer those in light o f the guidance in EITF 96-19?
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Under the provisions of EITF 96-16, third party costs incurred in the exchange or 
modification of debt are expensed as incurred. We do not believe this is appropriate for 
insurance contracts. Traditionally, commissions have comprised a significant portion of 
DAC. FASB Statement No. 60 requires that the costs that vary with and are primarily 
related to the acquisition of the replacement contract (e.g., commissions, underwriting 
costs, and certain other costs incurred to replace the old contract with the new) should be 
deferred. We believe that the guidance in FASB Statement No. 60 and FASB 
Statement No. 97 regarding deferrable expenses should be applied to third party expenses 
associated with replacement contracts.
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A m e r ic a n  A c a d e m y  o f A c t u a r ie s
DATE: September 29, 1999
TO: American Institute of Certified Public Accountants
FROM: Daniel J. Kunesh — American Academy of Actuaries
RE: COMMENTS ON JUNE 25, 1999 DISCUSSION PAPER "ACCOUNTING BY
LIFE INSURANCE ENTERPRISES FOR DEFERRED ACQUISITION COSTS 
ON INTERNAL REPLACEMENTS OTHER THAN THOSE COVERED BY 
FASB STATEMENT NO. 97"
The American Academy of Actuaries’ Committee on Life Insurance Financial Reporting 
(COLIFR) appreciates the opportunity to comment on the above-referenced document 
(Discussion Paper). Our attached comments are intended to be consistent both with the language 
and intent of the discussion contained in the Discussion Paper.
COLIFR appreciates the complexity of some of the issues involved and welcomes correspondence 
and discussion about the matters raised in the attached commentary and any other matters your 
Task Force may wish to discuss with us.
The American Academy of Actuaries is the public policy organization for actuaries practicing in 
all specialties within the United States. A major purpose of the Academy is to act as the public 
information organization for the profession. The Academy is non-partisan and assists the public 
policy process through the presentation of clear and objective actuarial analysis. The Academy 
regularly prepares testimony for Congress, provides information to federal elected officials, 
comments on proposed federal regulations, and works closely with state officials on issues related 
to insurance. The Academy also develops and upholds actuarial standards of conduct, 
qualification and practice, and the Code of Professional Conduct for all actuaries practicing in the 
United States.
TO: American Institute of Certified Public Accountants
FROM: The Committee on Life Insurance Financial Reporting of the American Academy
of Actuaries
DATE: September 29, 1999
RE: Comments on AICPA Discussion Paper “Accounting by Life Insurance Enterprises for
Deferred Acquisition Costs on Internal Replacements Other Than Those Covered by 
FASB Statement No. 97”, dated June 25, 1999
Issue 1: Is authoritative guidance needed on the accounting by life insurance enterprises for 
deferred acquisition costs (DAC) in situations characterized as internal replacements?
• Guidance is needed to promote consistency of practice. The statement in paragraph 19 of 
Practice Bulletin 8 that “the accounting for other internal replacements should be based on the 
circumstances of the transaction” does not do much for consistency of practice.
• Practice Bulletin 8 does not elaborate on why continued deferral is not appropriate when 
traditional contracts are replaced with universal-life type contracts but may be appropriate in 
other circumstances. Any new guidance ofFered should try to address this.
• Notable diversity of practice is found in internal replacement programs in Europe (under US 
GAAP), in updates and upgrades of accident and health coverage in the US, and in the US life 
and annuity markets.
• This is an increasingly important issue as companies introduce new products, implement 
retention programs, and focus on customer profitability.
Issue 2: Which of the views presented herein is most appropriate? Are there other views 
that should be considered?
• We support the conclusion that continued deferral of DAC may be sometimes appropriate, 
and therefore disagree with View A. View A, expressed in Paragraph 8 of the Discussion 
Paper, appears to have an internal inconsistency. It indicates that the write-off of costs should 
be extended by analogy to all types of replacements, which we interpret as no opportunity to 
carry-over costs in any situation. Paragraph 10, however, suggests that FASB’s restriction in 
Statement 97 was appropriate to the products then under discussion, and may not be reflective 
of the FASB’s views on other kinds of replacements. We interpret this statement to suggest 
there may be situations where carry-over is appropriate.
• Both View B and View C conclude that continued deferral of DAC might be sometimes 
appropriate.
2
• The criteria for eligibility for deferral treatment is the balancing issue. View B hinges on the 
view that the “internal replacement transaction represents a continuation of a contractual 
relationship” between the insurer and the insured. This logic has a great deal of appeal.
• We support View B for the following reasons:
1. An internal replacement program is generally designed to preserve or improve the 
ongoing economics of the customer relationship; these programs have become an integral 
part of the product development cycle.
2. The ability to carry-over amounts in a replacement situation creates an accounting 
model consistent with the economic motives of the replacement. A reported GAAP loss 
during the period that the relationship with the customer has been changed or extended is 
inconsistent with the economic reality of the transaction. Thus, carrying over the original 
DAC would avoid the inconsistent pattern of gains, followed by a loss in year of 
replacement, followed by gains.
3. The flexibility of today’s insurance contracts already allows modification of the 
company-customer relationship. A replacement may be a more visible modification, but 
in substance can often be similar to flexible transactions allowed within a contract.
• View C looks to the terms of the initial and replacement contracts as the chief criteria for 
eligibility for deferral of DAC. These criteria could be useful in a larger context, which 
recognizes the nature of insurance obligations and risks.
• It should be noted that debt instruments, which serve as the replacement model for View C, 
have markedly different underlying obligations and risks compared to insurance. Debt is an 
obligation between two sophisticated corporate entities. The exchange or modification of a 
debt instrument is often under terms that are negotiated between the parties to the debt. In 
contrast, an insurance replacement program operates between an insurer, who defines the 
terms of the replacement program, and the insured individual, who has the option to elect the 
new arrangement or stay with the original contractual guarantees. The risks underlying debt 
include default risk and credit risk. By contrast, insurance risks are distinct and broader 
ranged. This is discussed more under Issue 6 below.
Issue 3: What criteria can be developed for determining whether a replacement is between contracts 
that are substantially similar?
• Basic guidance could preclude crossover between lines of coverage, e.g. between life 
insurance / annuities / accident and health.
• Significant differences between the covered contingencies of the old and new contracts may 
also preclude replacement classification. This could, for example, prohibit crossovers 
between major medical / hospital / Medicare supplement / cancer / long term care and other 
similar coverage.
• The members of our committee share differing views on whether a change in GAAP 
classification should call for treatment as a new contract. A classical example is an annuity
3
contract that has two phases (accumulation and payout) and may be classified as a SFAS 97 
contract in the accumulation phase and a SFAS 60 contract in the payout phase.
• The guidance should provide specific criteria for deciding whether an internal replacement 
program should be accounted for as the continuation of an existing insurance program or as 
the issuance of a new block of business. For example, the replacement of one SFAS 60 
contract with another may clearly qualify as an internal replacement for accounting purposes 
if certain criteria are satisfied. Examples of reasonable criteria are provided under Issue 5 
below.
Issue 4: What costs (if any) should be considered as eligible costs for deferral in a 
replacement transaction?
• All costs that meet the SFAS 60 criteria of variability and attribution should be considered -  
agent compensation, commissions or agent bonuses for assisting in the replacement process, 
policy reissuance costs, any underwriting costs for an increase in the risk assumed by the 
insurer.
• Additionally, consideration should be given to any costs associated with making a 
replacement offer to existing policyholders, such as a mailing describing the offering.
• Arguably, inducements offered to policyholders as an incentive to replace one contract with 
another might be considered. These include bonus interest credits, premium credits and 
discounts.
• Any difference between the previous net GAAP reserve and the cash value transferred (which 
may include waiver of a surrender charge) should be considered. This difference may result 
in the deferral of a gain or loss, depending on the relationship of the net GAAP reserve to the 
transferred cash value. Alternatively, the deferred amount could be broken into its two 
components: the unamortized portion of DAC on the old contract plus the difference in 
benefit reserve on the old contract and cash value transferred.
• One option could be to limit combined (carryover and new) amounts deferred to an amount 
that would otherwise accrue to a new contract. Alternatively, we may suggest the newly 
replaced contract has a profitability profile no less than that of a similar, newly issued 
contract. In other words, amounts deferred may be further limited due to other factors, such 
as the impact on mortality margin in a replacement situation where no underwriting is done.
Issue 5: What other issues or practical considerations should be examined related to this 
topic?
• DAC is often valued on a block of business, rather than contract by contract, basis. Some 
guidance may be needed as to how to allocate unamortized DAC among contracts when 
continuing deferral after an internal replacement.
• According to paragraph 16 of the Discussion Paper, EITF 96-19 concluded that old and new 
fees deferred when a transaction “is not accounted for as debt extinguishment” should be
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amortized over the remaining term of the replaced debt. This might be difficult in internal 
replacement situations. Likewise it may be administratively impossible to amortize old 
amounts over the old term and new amounts over a new term. It would be more practical to 
allow amortization of old and new amounts over a term appropriate to the new contract.
• There are a number of transactional characteristics that can help to distinguish a 
“replacement” from a “new” contract. Examples are the benefits provided, the level of 
commissions or other acquisition costs relative to a new contract, and marketing 
circumstances, such as an offer limited to existing policyholders only. Reasonable evidence 
for treatment as a replacement would be similarity of benefits provided, a reduction in 
commissions or other acquisition costs relative to a new contract, and an offering limited to 
existing policyholders only. Other evidence could include simplified or no new medical 
underwriting, the manner in which the replacement policy is handled in the administrative 
system, and in some cases, original policy dating. However, a company’s inability to identify 
the original policy date in its administration system should not preclude treatment as a 
replacement if other evidence clearly indicates a replacement.
• Examples will be needed in the guidance as to qualifying and non-qualifying internal 
replacement situations.
•  Guidance on the required similarity of the replacement product to the original product will be 
needed.
• Guidance is needed on whether or not historical profit margins need to be considered in the 
amortization of DAC for replacement products that are subject to ongoing unlocking due to 
experience -  SFAS 97 investment and universal life-type contracts, and SOP 95-1 
participating contracts. The inclusion of historical profit margins in DAC amortization can 
present a number of practical problems, which suggest that a prospective-only approach may 
be the only feasible solution. A purist approach would require a policy-level backcasting of 
old product profit margins appended to a forecast of expected replacement product profit 
margins. However, very few companies are able to capture estimated profit margins at the 
policy level. Most companies perform DAC amortization at an aggregate level.
• The guidance should anticipate areas of potential abuse. For example, a company may be in 
a situation where a product with 100 bp margin can replace an old product with initial 
expectations of a 200 bp profit margin and revised expectations of 100 bp of profit margin. 
The old product, in the absence of replacement, would have experienced an acceleration of 
DAC amortization that could have led to GAAP losses. Replacement with a newer, more 
competitive product could mean that there is no DAC write-down, if amortization is to only 
consider future product revenue (premium, profits or margins). In the absence of other 
circumstances, such a company may be motivated to encourage policy replacement to avoid a 
DAC write-down.
• In setting guidance to avoid abuses, certain other questions should also be considered by the 
AICPA. Should an increase in the DAC balance for a replacement policy be limited, due to a 
revision in the expectations for future profits? Could the carryover of a DAC balance from
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one contract to another lead to a permanent DAC? Could replacements be used as a means of 
extending the amortization period?
• We believe that most replacement programs are initiated for reasons other than accounting 
result and an ability to avoid losses or delay DAC amortization. Accordingly, we believe the 
potential for abuse should not by itself preclude the carry over of DAC in true replacement 
situations.
Issue 6: The Insurance Companies Committee would like to further investigate the analogy between 
internal replacements and modification or exchanges of debt instruments....
• The analogy between internal replacements and modifications or exchanges of debt 
instruments is carried too far. There is some similarity between a company’s responsibility to 
an insured in its contractual promise of benefits, given the occurrence of the covered risk(s), 
and that of a debt between a lender and borrower. However, the nature of the risks is different 
(credit and default risk vs. insurance risk). Furthermore the reasons for restructuring a debt 
are generally quite different than the reasons that a company endorses its internal replacement 
program. These are ignored by the FASB in its discussion in paragraph 72 of SFAS 97 and in 
the Discussion Paper, in paragraphs 13 through 17. The Discussion Paper presents the 
analogy without analysis of the nature of the risks or the reasons for the transactions.
• Of particular concern is the analogy drawn to EITF 96-19 and the 10% difference in the 
present value of the cash flows as the criteria for “substantially different”. As stated earlier, 
debt and insurance contracts, while similar in some respects, are still quite different. Many of 
the health updates result in an improved product structure, for a higher premium. It is 
possible that many or most would fail the 10% test, if imposed on insurance internal 
replacement situations.
• According to paragraph 16 of the Discussion Paper, EITF 96-19 concluded that “costs 
incurred with third parties....should be expensed as incurred.” This sounds onerous in the 
context of insurance transactions. Are agents third parties? What about medical information 
providers?
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Ms. Kim K. Hekker, CPA
Accounting Standards File 3162
American Institute of Certified Public Accountants
1211 Avenue of the Americas
New York, New York 10036-8775
Dear Ms. Hekker:
Discussion Paper: “ Accounting by Life Insurance Enterprises for Deferred 
Acquisition Costs on Internal Replacements Other Than Those covered by FASB 
Statement No. 97”
We appreciate the opportunity to provide comments on the Discussion Paper. KPMG 
believes that authoritative guidance is needed regarding the accounting by life insurance 
enterprises for deferred acquisition costs in situations characterized as internal 
replacements. Authoritative guidance would reduce the diversity in current practice and 
provide more comparable financial information for life insurance enterprises. The 
consistent application of accounting principles for these transactions would improve the 
ability of companies to operate on a level playing field.
In the basis for conclusion to FASB Statement No. 97, Accounting and Reporting by 
Insurance Enterprises for Certain Long-Duration Contracts and for Realized Gains and 
Losses from the Sale o f Investments (“Statement 97”), the FASB stated that the related 
acquisition costs follow the contract, not the continuing relationship with the customer. 
In addition, the FASB recognized that the objective of these transactions was often to 
retain the customer base. Paragraph 72 further states: “That objective is not, however, 
different from the objectives of similar transactions undertaken by insurance enterprises 
and other enterprises for which continued deferral of costs is not permitted, including the 
refunding of debt.” In the basis for conclusion to Statement 97, the FASB goes on to 
reference specific paragraphs in the conclusion of APB Opinion No. 26, Early 
Extinguishment o f Debt as amended by FASB Statement No. 76(“APB No. 26”). 
Paragraph 19 APB No. 26 is quoted in paragraph 72 of Statement 97, stating that “all 
extinguishments of debt are fundamentally alike.” Paragraph 20 of APB No. 26 required 
that the difference between the carrying amount of the extinguished debt and the
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reacquisition price be recorded currently in earnings. The FASB’s conclusion to write 
off the unamortized acquisition costs related to the replaced contract in paragraph 26 of 
Statement 97 was based on the then current literature on accounting for debt 
extinguishment.
In September 1996, the EITF began discussion on Issue 96-19, Debtor’s Accounting for 
a Modification or Exchange o f Debt Instruments (“EITF 96-19”). Since the FASB’s 
conclusion on internal replacements in Statement 97, issued in December 1987 was 
developed with reference to the debt literature, we believe that subsequent interpretation 
of that literature in the form of EITF 96-19 would seem to be relevant to the accounting 
for internal replacements.
The FASB and EITF have concluded that substantial modification of terms of a debt 
instrument should be accounted for like, and reported in the same manner as, an 
extinguishment. Application of that principle to contracts issued by insurance 
enterprises would result in deferred acquisition costs being written off in connection 
with a modification that is sufficiently significant to constitute an extinguishment. The 
EITF explicitly stated that an exchange or modification of terms that does not result in a 
substantially different contract does not constitute an extinguishment. In such cases, the 
deferred acquisition costs related to the original contract continue to be amortized over 
the term of the replacement contract. Any new deferred acquisition costs incurred to 
achieve the modification would be expensed as incurred.
KPMG believes there is support in the accounting literature for View C. EITF 96-19 
provided a cash flow test to determine when a replacement of one contract with another 
is substantially different. KPMG believes that a cash flow test analogous to that 
described in EITF 96-19 is appropriate only if such an approach could be operational for 
contracts issued by life insurance companies that are subject to internal replacement.
The issues summaries for EITF 96-19 document that the working group believed the 
approach for determining if a change or modification of terms of a debt instrument is 
substantially different should be “simple and straight-forward.” The consensus of EITF 
96-19 states: “From a debtor’s perspective, an exchange of debt instruments between or 
a modification of a debt instrument by a debtor and a creditor in a nontroubled debt 
situation is a deemed to have been accomplished with debt instruments that are 
substantially different if the present value of the cash flows under the terms of the new
debt instrument is at least 10 percent different from the present value of the remaining 
cash flows under the terms of the original instrument.
The terms of contracts issued by insurance enterprises can differ significantly from the 
terms of debt instruments. Investment and insurance contracts often do not have a stated 
maturity or a stated interest rate. Contracts issued by insurance companies are basically 
due on demand, although surrender charges may be imposed as penalties for early 
withdrawal. Interest rates are often reset at the discretion of the company, which makes 
it difficult to determine an effective yield over the life of the contract. In addition, such 
contracts have various payment options on death or annuitization and different 
mechanisms to impose fees on the contractholder, such as cost of insurance charges and 
maintenance and expense charges. The unique features of these contracts may make it 
difficult to perform consistent cash flow analysis from company to company, given the 
extent of assumptions to be made in the cash flow analysis.
KPMG would support View C, as long as an operational approach can be developed for 
distinguishing between modifications that result in a substantially different contract and 
those that do not. In that regard, standard setters should consider not only quantitative 
indicators, but also whether changes in the qualitative characteristics of these contracts 
suggest that a modification of terms results in a substantially different contract. For 
example, if the replacement contract has variable terms and the original contract had 
fixed terms or if one of the contracts is deemed to be an insurance contract pursuant to 
Statement 97 and the other is an investment contract, then the replacement contract 
might be deemed to be substantially different. In many cases, we would expect that to 
induce the contractholder to agree to the internal replacement, a company needs to offer 
a significant economic benefit to the contractholder, which generally would mean that 
the replacement contract was substantially different from the original contract. However, 
we can envision certain limited circumstances where for administrative or regulatory 
purposes, such as offering a different array of investment options under a contract, 
companies will offer internal replacements that are not substantially different 
economically. In those cases, it would appear that the economics of the original contract 
remain in place and it would not be appropriate to write off the original deferred 
acquisition costs. Costs related to the new contract would then be charged to expense as 
incurred.
If operational criteria for assessing when a contract replacement is substantially different 
cannot be developed, KPMG supports View A. View A proposes that unamortized
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acquisition costs related to the original contract be written off at the time the original 
contract is terminated and the new contract is issued.
Costs eligible for deferral in a replacement contract are those costs that meet the 
definition of deferred acquisition costs pursuant to FASB Statement No. 60, 
“Accounting for Insurance.” No additional guidance on this matter is needed in 
connection with the issue of internal replacements.
We appreciate the opportunity to comment on this Discussion Paper. If you have any 
questions concerning our comments or wish to discuss them further, please contact Ellen 
Hancock at 212-909-5626.
Very truly yours,
K PM G  llp
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